PMID: 8461927Apr 1, 1993Paper

Autoantibodies in central nervous system lupus

British Journal of Rheumatology
E M Hay, D A Isenberg

Abstract

Central nervous system (CNS) involvement in patients with lupus remains both a diagnostic and a therapeutic challenge. The role of autoantibodies in the pathogenesis of CNS lupus and/or as markers for disease activity is reviewed. Doubt is cast on the value of measuring anti-neuronal antibodies. Those antibodies binding ribosomal-P protein antigens or certain phospholipids appear to have greater utility, although even in these cases there is no uniform agreement as to their precise role in CNS disease induction, or how well antibody levels reflect disease activity.

Citations

May 12, 2001·Journal of the American Geriatrics Society·G A HeckmanJ A Denburg
Aug 6, 2002·Journal of Neuroimmunology·Boris SakicHenry Szechtman
Feb 11, 2003·Brain Research·David A BallokBoris Sakic
Jul 1, 1995·Psychosomatics·L V Calabrese, T A Stern
Mar 23, 2005·Biological Psychiatry·Boris SakicJason M Millward
Apr 1, 1995·Seminars in Arthritis and Rheumatism·C A von Mühlen, E M Tan
Jun 30, 2004·Journal of Neuroimmunology·David A BallokBoris Sakic
Mar 22, 2001·Brain, Behavior, and Immunity·B SakićH Szechtman
Feb 14, 2015·Future Neurology·Xiaohua XuMoses Rodriguez
Aug 14, 1997·Annals of the New York Academy of Sciences·P M Moore
Aug 14, 1997·Annals of the New York Academy of Sciences·J CrimandoS A Hoffman
Jan 1, 1994·Scandinavian Journal of Rheumatology·G L Iverson, K W Anderson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.